WSO - April 2023 - 411

Chen et al.
411
Table 1. Sub-distribution hazard ratio of stroke in different multivariable Cox models.
Non-ITP vs ITP
Non-ITP
Overall stroke
Event
Person-year
Incidence rate (per 1000 person-year)
Crude SHR
Model 1: aSHR (95% CI)
Model 2: aSHR (95% CI)
Model 3: aSHR (95% CI)
Model 4: aSHR (95% CI)
Hemorrhagic stroke
Event
Person-year
Incidence rate (per 1000 person-year)
Crude SHR
Model 1: aSHR (95% CI)
Model 2: aSHR (95% CI)
Model 3: aSHR (95% CI)
Model 4: aSHR (95% CI)
Ischemic stroke
Event
Person-year
Incidence rate (per 1000 person-year)
Crude SHR
Model 1: aSHR (95% CI)
Model 2: aSHR (95% CI)
Model 3: aSHR (95% CI)
Model 4: aSHR (95% CI)
4803
446,345
10.76
Ref.
Ref.
Ref.
Ref.
Ref.
772
446,345
1.73
Ref.
Ref.
Ref.
Ref.
Ref.
4227
446,345
9.47
Ref.
Ref.
Ref.
Ref.
Ref.
ITP
1445
120,445
12.00
1.14 (1.08-1.21)*
1.23 (1.16-1.31)*
1.22 (1.15-1.30)*
1.31 (1.23-1.39)*
1.30 (1.23-1.39)*
371
120,445
3.08
1.79 (1.58-2.03)*
1.96 (1.73-2.23)*
1.96(1.72-2.22)*
1.94 (1.71-2.21)*
1.93 (1.70-2.20)*
1110
120,445
9.22
0.99 (0.93-1.06)
1.06 (0.99,1.14)
1.06 (0.99-1.13)
1.15 (1.07-1.23)*
1.14 (1.07-1.22)*
ITP: immune thrombocytopenia; CI: confidence interval; SHR: sub-distribution hazard ratio; CAD: coronary artery disease; CKD: chronic kidney
disease; COPD: chronic obstructive pulmonary disease.
Model 1: age, sex.
Model 2: age, sex, monthly income, urbanization.
Model 3: Model 2, hypertension, diabetes, hyperlipidemia, CAD, CKD, cancer, COPD, sleep apnea, atrial fibrillation, heart failure.
Model 4: Model 3, aspirin, metformin, statin.
*p < 0.001.
International Journal of Stroke, 18(4)

WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023

Contents
WSO - April 2023 - Cover1
WSO - April 2023 - Cover2
WSO - April 2023 - 375
WSO - April 2023 - Contents
WSO - April 2023 - 377
WSO - April 2023 - 378
WSO - April 2023 - 379
WSO - April 2023 - 380
WSO - April 2023 - 381
WSO - April 2023 - 382
WSO - April 2023 - 383
WSO - April 2023 - 384
WSO - April 2023 - 385
WSO - April 2023 - 386
WSO - April 2023 - 387
WSO - April 2023 - 388
WSO - April 2023 - 389
WSO - April 2023 - 390
WSO - April 2023 - 391
WSO - April 2023 - 392
WSO - April 2023 - 393
WSO - April 2023 - 394
WSO - April 2023 - 395
WSO - April 2023 - 396
WSO - April 2023 - 397
WSO - April 2023 - 398
WSO - April 2023 - 399
WSO - April 2023 - 400
WSO - April 2023 - 401
WSO - April 2023 - 402
WSO - April 2023 - 403
WSO - April 2023 - 404
WSO - April 2023 - 405
WSO - April 2023 - 406
WSO - April 2023 - 407
WSO - April 2023 - 408
WSO - April 2023 - 409
WSO - April 2023 - 410
WSO - April 2023 - 411
WSO - April 2023 - 412
WSO - April 2023 - 413
WSO - April 2023 - 414
WSO - April 2023 - 415
WSO - April 2023 - 416
WSO - April 2023 - 417
WSO - April 2023 - 418
WSO - April 2023 - 419
WSO - April 2023 - 420
WSO - April 2023 - 421
WSO - April 2023 - 422
WSO - April 2023 - 423
WSO - April 2023 - 424
WSO - April 2023 - 425
WSO - April 2023 - 426
WSO - April 2023 - 427
WSO - April 2023 - 428
WSO - April 2023 - 429
WSO - April 2023 - 430
WSO - April 2023 - 431
WSO - April 2023 - 432
WSO - April 2023 - 433
WSO - April 2023 - 434
WSO - April 2023 - 435
WSO - April 2023 - 436
WSO - April 2023 - 437
WSO - April 2023 - 438
WSO - April 2023 - 439
WSO - April 2023 - 440
WSO - April 2023 - 441
WSO - April 2023 - 442
WSO - April 2023 - 443
WSO - April 2023 - 444
WSO - April 2023 - 445
WSO - April 2023 - 446
WSO - April 2023 - 447
WSO - April 2023 - 448
WSO - April 2023 - 449
WSO - April 2023 - 450
WSO - April 2023 - 451
WSO - April 2023 - 452
WSO - April 2023 - 453
WSO - April 2023 - 454
WSO - April 2023 - 455
WSO - April 2023 - 456
WSO - April 2023 - 457
WSO - April 2023 - 458
WSO - April 2023 - 459
WSO - April 2023 - 460
WSO - April 2023 - 461
WSO - April 2023 - 462
WSO - April 2023 - 463
WSO - April 2023 - 464
WSO - April 2023 - 465
WSO - April 2023 - 466
WSO - April 2023 - 467
WSO - April 2023 - 468
WSO - April 2023 - 469
WSO - April 2023 - 470
WSO - April 2023 - 471
WSO - April 2023 - 472
WSO - April 2023 - 473
WSO - April 2023 - 474
WSO - April 2023 - 475
WSO - April 2023 - 476
WSO - April 2023 - 477
WSO - April 2023 - 478
WSO - April 2023 - 479
WSO - April 2023 - 480
WSO - April 2023 - 481
WSO - April 2023 - 482
WSO - April 2023 - 483
WSO - April 2023 - 484
WSO - April 2023 - 485
WSO - April 2023 - 486
WSO - April 2023 - 487
WSO - April 2023 - 488
WSO - April 2023 - 489
WSO - April 2023 - 490
WSO - April 2023 - Cover3
WSO - April 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com